- AMRA is the only European company in the Diagnostics segment to receive the highest designation, recognizing its work in MRI-based muscle and fat analysis.
The 2026 result builds on AMRA’s inclusion in the inaugural ranking in 2025, when the company received a “Very High” designation. Its advancement to the top category reflects continued progress in scientific excellence and technological innovation, as well as the expanding application of MRI-based biomarkers across research, drug development, and clinical care.
“Being recognized by TIME (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftime.com%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=TIME&index=1&md5=539d28457492931f46992041ae5786da) and Statista (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.statista.com%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=Statista&index=2&md5=ad95c023d2b0897c0b7ba1b2192c558d) for the second consecutive year and receiving the highest ‘Outstanding’ designation is a meaningful recognition of AMRA’s continued progress,” said Olof Dahlqvist Leinhard, CEO of AMRA Medical. “It reflects the dedication of our team and the strong scientific foundation behind our work. Our mission is to advance the understanding of health and disease through MRI-based biomarkers, and we are proud to see that work recognized on a global stage.”
At AMRA, our work is centered on looking beyond conventional body composition measures to uncover Insights Within the human body. Through standardized MRI-based biomarkers and deep scientific expertise, we help researchers, pharmaceutical companies, and healthcare professionals gain a more detailed understanding of fat distribution and muscle composition across metabolic and neuromuscular health.
“Recognition from TIME and Statista reinforces the growing global relevance of AMRA’s work,” said Leanna Kellerman, Chief Globalization Officer at AMRA Medical. “As healthcare and life sciences increasingly look for more precise, data-driven ways to understand health and disease, we see significant opportunities to bring the insights enabled by AMRA’s MRI-based biomarkers to more organizations and markets around the world. This recognition strengthens our ambition to expand AMRA’s global reach and impact.”
Being selected in both editions of the World’s Top HealthTech Companies list reinforces our commitment to pushing body composition science forward and continuing to deliver meaningful insights for our partners around the world.
The full ranking, and more information about the selection process, is available to view on TIME.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftime.com%2Farticle%2F2026%2F09%2F16%2Fworlds-top-healthtech-companies-2026%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=TIME.com&index=3&md5=c2683008f46dcf68695af6880fcd79d1)
Explore Research Services → (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Famramedical.com%2Fservices%2Fresearch-services%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=Explore+Research+Services+%26%238594%3B&index=4&md5=da6f3d2f18155b59be8b06ca36a62c1b)
Explore Clinical Services → (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Famramedical.com%2Fservices%2Fclinical-services%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=Explore+Clinical+Services+%26%238594%3B&index=5&md5=ad1ff8abc8ddad4c3afa99516dfa48e8)
About AMRA Medical
AMRA Medical is a global leader in health informatics, pioneering the field of fat and muscle analysis with proprietary, MRI-based technologies. Our gold-standard platform delivers highly precise and standardized biomarkers, providing an advanced understanding of metabolic and musculoskeletal health that surpasses conventional measures of muscle and fat. These insights play a critical role in optimizing clinical trial design, improving endpoint selection, and supporting data-driven decision-making in both research and clinical practice.
Built on rigorous science and driven by continuous innovation, AMRA’s solutions are designed to meet the complex demands of modern healthcare and pharmaceutical development. Through standardized, cloud-based workflows and strategic collaboration, we enable partners to access actionable data with clarity and confidence-accelerating progress from early-stage discovery to impactful clinical outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260917956850/en/
언론연락처: AMRA Medical Melinda Perjons Communication Strategist
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
“Being recognized by TIME (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftime.com%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=TIME&index=1&md5=539d28457492931f46992041ae5786da) and Statista (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.statista.com%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=Statista&index=2&md5=ad95c023d2b0897c0b7ba1b2192c558d) for the second consecutive year and receiving the highest ‘Outstanding’ designation is a meaningful recognition of AMRA’s continued progress,” said Olof Dahlqvist Leinhard, CEO of AMRA Medical. “It reflects the dedication of our team and the strong scientific foundation behind our work. Our mission is to advance the understanding of health and disease through MRI-based biomarkers, and we are proud to see that work recognized on a global stage.”
At AMRA, our work is centered on looking beyond conventional body composition measures to uncover Insights Within the human body. Through standardized MRI-based biomarkers and deep scientific expertise, we help researchers, pharmaceutical companies, and healthcare professionals gain a more detailed understanding of fat distribution and muscle composition across metabolic and neuromuscular health.
“Recognition from TIME and Statista reinforces the growing global relevance of AMRA’s work,” said Leanna Kellerman, Chief Globalization Officer at AMRA Medical. “As healthcare and life sciences increasingly look for more precise, data-driven ways to understand health and disease, we see significant opportunities to bring the insights enabled by AMRA’s MRI-based biomarkers to more organizations and markets around the world. This recognition strengthens our ambition to expand AMRA’s global reach and impact.”
Being selected in both editions of the World’s Top HealthTech Companies list reinforces our commitment to pushing body composition science forward and continuing to deliver meaningful insights for our partners around the world.
The full ranking, and more information about the selection process, is available to view on TIME.com (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftime.com%2Farticle%2F2026%2F09%2F16%2Fworlds-top-healthtech-companies-2026%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=TIME.com&index=3&md5=c2683008f46dcf68695af6880fcd79d1)
Explore Research Services → (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Famramedical.com%2Fservices%2Fresearch-services%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=Explore+Research+Services+%26%238594%3B&index=4&md5=da6f3d2f18155b59be8b06ca36a62c1b)
Explore Clinical Services → (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Famramedical.com%2Fservices%2Fclinical-services%2F&esheet=54606159&newsitemid=20260917956850&lan=en-US&anchor=Explore+Clinical+Services+%26%238594%3B&index=5&md5=ad1ff8abc8ddad4c3afa99516dfa48e8)
About AMRA Medical
AMRA Medical is a global leader in health informatics, pioneering the field of fat and muscle analysis with proprietary, MRI-based technologies. Our gold-standard platform delivers highly precise and standardized biomarkers, providing an advanced understanding of metabolic and musculoskeletal health that surpasses conventional measures of muscle and fat. These insights play a critical role in optimizing clinical trial design, improving endpoint selection, and supporting data-driven decision-making in both research and clinical practice.
Built on rigorous science and driven by continuous innovation, AMRA’s solutions are designed to meet the complex demands of modern healthcare and pharmaceutical development. Through standardized, cloud-based workflows and strategic collaboration, we enable partners to access actionable data with clarity and confidence-accelerating progress from early-stage discovery to impactful clinical outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260917956850/en/
언론연락처: AMRA Medical Melinda Perjons Communication Strategist
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
ⓒ DNN & dnnkorea.kr 무단전재-재배포금지
BEST 뉴스
-
남수단 대통령 특사 방한… 한국·남수단 협력의 새 장 열다
이태석재단을 방문한 아둣 살바 키르 마야르디트 남수단 특사와 대표단이태석 신부의 사랑과 헌신으로 시작된 한국과 남수단의 인연이 양국의 실질적인 협력으로 이어지고 있다. 이태석재단(이사장 구수환)은 살바 키르 남수단 대통령의 장녀인 아둣 살바 키르 마야르디트 대통령 특사를 초청해 3박 4일간의 방한 일정... -
도봉노인종합복지관, 개관 26주년 기념 ‘도봉 어르신 문화축제’ 성료
도봉 어르신 문화축제 전경서울시립도봉노인종합복지관(관장 이은주)은 개관 26주년 및 노인의 날을 맞아 지난 10월 13일(화) 지역 어르신과 주민 약 1000명이 참여한 가운데 2026년 도봉 어르신 문화축제 ‘스스로 스마트를 즐기자!’를 성황리에 마쳤다고 밝혔다. 이번 축제는 스마트 기기와 AI 기술이 보편화되는 시대... -
국화꽃처럼 활짝 핀 웃음꽃… 디엔엔 사회적협동조합, 장애인과 함께한 행복한 가을 나들이
디엔엔 사회적협동조합(이사장 이채현)은 지난 11월 4일(수) 오전 11시, 장애인들과 함께 제26회 마산가고파국화축제 현장을 찾아 지역사회 탐방 행사를 진행했다. 이번 행사는 장애인들이 지역의 대표적인 문화축제를 직접 경험하고, 아름다운 자연과 문화를 함께 즐기며 지역사회 구성원으로서... -
한국자폐인사랑협회, 제1회 공익활동 임팩트 어워드 ‘행정안전부 장관상’ 수상
오른쪽부터 한국자폐인사랑협회 김용직 회장과 윤호중 행정안전부 장관이 대한민국 공익활동 임팩트 어워드 한국자폐인사랑협회 ‘행정안전부장관상 표창’ 기념 촬영을 하고 있다한국자폐인사랑협회(회장 김용직, 이하 ‘사랑협회’)는 10월 14일(수) 서울 여의도 FKI타워에서 개최된 ‘제1회 대한민국 공익활동 임팩트 어워... -
발달장애인과 함께하는 우리 동네 환경사랑! 산호동 줍킹 봉사활동
2026년 11월 6일(금) 오전, 디엔엔사회적협동조합은 봉사활동의 일환으로 발달장애인들과 함께 창원시 마산합포구 산호동 일대에서 '줍킹' 활동을 진행했다. 이번 활동은 발달장애인들이 지역사회의 일원으로서 환경보호에 직접 참여하고, 건강한 신체활동과 봉사활동을 통해 지역사회 참여... -
한국자폐인사랑협회, 발달장애인 재산관리지원서비스 성과보고회 성료
한국자폐인사랑협회, 발달장애인 재산관리지원서비스 성과보고회한국자폐인사랑협회(회장 김용직, 이하 ‘사랑협회’)는 10월 16일(금) 오후 2시 서울 여의도 이룸센터 누리홀에서 ‘2026년 한국자폐인사랑협회 재산관리지원서비스 성과보고회’를 개최했다고 밝혔다. 이번 성과보고회는 ‘발달장애인 재산관리 전문지원체계...
전체댓글 0
NEWS TOP 5
실시간뉴스
추천뉴스
포토뉴스
more +-
DNN 사회적협동조합·DNNKOREA.KR 출범
함께 꿈꾸는 미래’ 장애인과 지역사회의 눈이 되다… DNN 사회적협동조합·DNNKOREA.KR 출범 기업의 존재 이유를 단순한 ‘이윤 창출’에서 ‘사회적 가치 창출’로 과감히 전환하며 귀감이 되고 있는 기업이 있다. 지난 2024년 10월, 기업의 궁극적 목표를 사회공헌에 두고 장애인표준사업장을 설립하며 포용적 고용 생태계... -
고용노동부 근로감독관, A업체 ‘퇴직금 산정 오류’ 시정조치… 고용계약서 휴무일 기준도 명확히 정비
[현장포커스] 고용노동부 근로감독관, A업체 ‘퇴직금 산정 오류’ 시정조치… 고용계약서 휴무일 기준도 명확히 정비 고용노동부 소속 근로감독관(특별사법경찰관)이 관내 사업장을 대상으로 실시한 근로감독에서 A업체가 퇴직금을 법적 기준과 다르게 산정해 지급한 사실이 적발되어 시정조치를 받았다. 아울러 고용계약... -
진주교육청, 사회적 약자 기업의 판로 개척 및 상생 협력 기반 마련 간담회 개최
“사회적 약자 기업, 공공조달 실질적 경쟁력 확보 위해 제도 개선 시급” 진주교육지원청 간담회서 오세록 가림건설 조은창 대표, 구조적 한계 지적 가격 경쟁 비중 낮추고 ‘약자 지원·지역 업체’ 배점 확대 제안 [진주=DNN뉴스] 공공조달 시장에서 사회적 약자 기업이 실질적인 경쟁력을 확보할 수 있도록 제도를... -
“함께 꿈꾸는 미래” 디엔엔사회적협동조합, 새로운 출발
이채현 초대 이사장 중심으로 힘찬 출범… 장애인과 비장애인이 함께하는 사회적 가치 실현 디엔엔사회적협동조합이 ‘함께 꿈꾸는 미래’를 기치로 내걸고 새로운 출발을 알렸다. 디엔엔사회적협동조합은 최근 조합원들이 한자리에 모인 가운데 출범을 기념하고 앞으로의 활동 방향과 비전을 공유했다. 이날 참석자...
